BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1614086)

  • 21. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Attempts of orbit irradiation after enucleation of the eye with malignant choroidal melanoma. Part I].
    Mirkiewicz-Sieradzka B; Zygulska-Mach H; Romanowska B; Bryk J; Heitzman J; Ksiezyk M
    Klin Oczna; 1999; 101(4):287-90. PubMed ID: 10581897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Survival after treatment for malignant choroidal melanoma: comparison between conservative therapy (Ru106/Rh106 applicator) and enucleation with and without postoperative irradiation to the orbit; 1960 to 1979].
    Kiehl H; Kirsch I; Lommatzsch P
    Klin Monbl Augenheilkd; 1984 Jan; 184(1):2-14. PubMed ID: 6708380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radiotherapy of intraocular tumours, particularly of melanoma of the choroid (author's transl)].
    Lommatzsch PK
    Klin Monbl Augenheilkd; 1979 Jun; 174(6):948-58. PubMed ID: 480851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The regression behavior of choroid melanoma following radiotherapy--a new prognostic parameter?].
    Guthoff R; Haase J; von Domarus D; Draeger J; Lauritzen K
    Klin Monbl Augenheilkd; 1990 Jan; 196(1):6-10. PubMed ID: 2313997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of choroid melanoma with contact curietherapy using ruthenium 106].
    Muller RP; Busse H; Kroll P; Gast E
    J Fr Ophtalmol; 1985; 8(10):639-43. PubMed ID: 3833880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma.
    Tallberg T; Uusitalo R; Sarna S; Seregard S; Werschnik C
    Anticancer Res; 2000; 20(3B):1969-75. PubMed ID: 10928136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of histo-pathologic examination of three enucleated eyes with a choroidal melanoma after strontium-90 irradiation.
    Parys-van Ginderdeuren R; van den Oord JJ; Missotten L
    Bull Soc Belge Ophtalmol; 1997; 265():47-54. PubMed ID: 9479819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors of choroidal melanoma: an anatomo-clinical retrospective and statistical study of 76 enucleated cases].
    Panigel K; Hedelin G; Speeg-Schatz C; Sahel J; Brini A
    J Fr Ophtalmol; 1992; 15(6-7):410-4. PubMed ID: 1294598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
    Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
    Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A risk of metastasis of choroid melanoma after brachytherapy].
    Brovkina AF; Val'skiĭ VV; Gusev GA; Panteleeva OG; Iurovskaia NN
    Vestn Oftalmol; 2003; 119(2):26-8. PubMed ID: 13678004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local tumor control after 106Ru brachytherapy of choroidal melanoma.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):385-91. PubMed ID: 15913907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Iodine 125 curietherapy of choroidal melanomas. Values of the technique and initial results].
    Meyer L; Wagner JP; Benichou C; Hermsdorff C; Sahel JA
    J Fr Ophtalmol; 1996; 19(12):755-60. PubMed ID: 9033900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
    Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
    Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echographic follow-up of malignant melanoma of the choroid after brachytherapy with 106Ru.
    Novak-Andrejcic K; Jancar B; Hawlina M
    Klin Monbl Augenheilkd; 2003 Dec; 220(12):853-60. PubMed ID: 14704943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.
    Collaborative Ocular Melanoma Study Group
    Arch Ophthalmol; 2006 Dec; 124(12):1684-93. PubMed ID: 17159027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
    Wilson MW; Hungerford JL
    Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.
    Filì M; Trocme E; Bergman L; See TRO; André H; Bartuma K; Girnita L; All-Eriksson C; Seregard S; Stålhammar G
    Br J Ophthalmol; 2020 Jan; 104(1):26-32. PubMed ID: 30910871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.